The BHQ-Ill is a Fully Automatic Molecule Workstation that integrates nucleic acid lysis, PCR amplification, data analysis, and result printing into a seamless workflow.
This equipment mainly consists of a positive and negative pressure gas path system, a temperature control system, a three-dimensional mobile platform, a reagent adding module, an image detection system, and application software. It is used in conjunction with multi-pathogen nucleic acid combined detection kits based on cartridge detection technology.
Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer (BHQ-Ill)
Diarrhea Viruses Nucleic Acid Detection Kit (qPCR)
Reproductive Tract Pathogens 6-Plex Nucleic Acid Detection Kit (qPCR)
Respiratory Pathogens Nucleic Acid Detection Kit (qPCR)
Fluorescence Immunoassay Analyzer (BH400-II)
Influenza A/B & Respiratory Virus Antigen Combination Test Kit
Founded in 2001, we have evolved into a high-tech biomedical enterprise that integrates R&D, production, sales, and after-sales service into a comprehensive system. The company operates a 40,000-square-meter integrated R&D center and is recognized as a leader in the field of inspection and testing.
In the biopharmaceutical sector, we possess strong independent R&D capabilities. Our fully automated nucleic acid detection products based on microfluidic technology are acclaimed as a "laboratory on a chip." Furthermore, we offer outstanding mass spectrometry products and exceptional user experiences in the life sciences sector.
Strategically, the enterprise manages multiple blood product manufacturing facilities and is continuously expanding with new-generation facilities for blood products and vaccines to serve global health needs.